News

Munich, Germany, 12-14 March, 2016: At the 31st Annual European Association of Urology (EAU) Congress the phytomedicine GRANU FINK® Prosta forte 500 mg…

Lugano, Switzerland, March 23, 2016: Helsinn Group is pleased to present its first group sustainability report, Quality of Life, demonstrating that…

A CURE-LIKE state has been achieved in a new Phase III study exploring the effects of baricitinib in rheumatoid arthritis patients with poor responses to…

MYSTERIOUS mechanisms of elastin tissue, a vital aspect of enabling our body to function, have finally been revealed through a novel combination of…

PARAMEDICS and physicians will soon see a cost-effective solution to stem cell use through the pragmatic use of seaweed to treat wounds, particularly in…

STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy

March 14, 2016: The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs…

A VACCINE that protects against nine types of the human papilloma virus (HPV) has been developed by research scientists; this offers significantly…